Finasteride is the most effective approved pill for male pattern hair loss, and it is also the treatment men worry about most. Online, you will find everything from “it’s completely safe” to horror stories. The trial data sits somewhere in the middle, and it is more useful than either extreme.

This article covers what placebo-controlled trials found, why those numbers should be read carefully, and what to do if you are considering the drug. Finasteride is prescription-only, so this is background for a conversation with your doctor, not a substitute for one.

What finasteride does

Finasteride blocks the enzyme 5-alpha reductase, which converts testosterone into DHT, the hormone that miniaturizes scalp follicles in men with pattern hair loss. Drake et al. (JAAD, 1999) showed that 1 mg daily lowers scalp and serum DHT substantially, and the large finasteride trials from the late 1990s (Kaufman et al., JAAD, 1998) established that it slows loss and regrows hair in many men.

Because DHT also plays roles outside the scalp, a possible effect on sexual function has been debated ever since.

The best summary of the placebo-controlled data

The cleanest way to estimate a drug’s side effects is to compare it with a placebo in double-blind trials. A 2018 systematic review and meta-analysis did exactly that for hair loss doses.

Put plainly: in these trials, the large majority of men on finasteride did not report sexual side effects, and a good share of the ones who did would have reported them on placebo anyway. The absolute difference was roughly two percentage points. That is a real signal, but it is not a common one.

Three reasons not to treat that number as the final word

1. Side effects were self-reported

The authors point out that sexual effects in all the trials were based on patient self-reports rather than validated questionnaires or objective measures. Most trials also did not record when symptoms started or whether they went away after stopping.

2. Reporting quality is uneven

A separate meta-analysis (Belknap et al., JAMA Dermatology, 2015) examined how adverse events were reported in finasteride trials for hair loss and concluded the reporting of sexual side effects was inadequate. Many trials did not systematically collect or describe them, which means the true rate could be higher or lower than the headline figures. Lee and colleagues also note that most of the trials had some relationship with pharmaceutical companies.

3. Earlier reviews disagreed

Mella et al. (Archives of Dermatology, 2010) found finasteride increased sexual dysfunction risk, while other meta-analyses cited by Lee et al. found no significant increase. Differences in which doses and trials were included explain much of the disagreement. This is why anyone who tells you the question is fully settled in either direction is overselling.

What about the nocebo effect?

A nocebo effect is when expecting side effects makes you notice or report them. There is evidence this matters for finasteride: Mondaini et al. (European Urology, 2007) found that men taking finasteride 5 mg for prostate enlargement reported more sexual side effects when they had been told about them beforehand than when they had not. That was a different population and a higher dose, so it does not prove the hair loss numbers are inflated. It does show that expectation changes reports, and that is why placebo-controlled data matter.

Nocebo does not mean side effects are imaginary. It means some share of reported symptoms is driven by expectation, and some share is real drug effect. The trials suggest both exist.

Persistent symptoms: what we do and do not know

Some men report that sexual or other symptoms continued after stopping finasteride. A 2017 report in PeerJ (Kiguradze et al.) described persistent erectile dysfunction in men exposed to finasteride or dutasteride. Reports like this raise a question; they cannot establish how often it happens, because they are not placebo-controlled and cannot rule out other causes. The trials above did not track recovery well, so good estimates do not currently exist. Anyone who tells you the rate is precisely X is guessing.

If you have already stopped or are thinking about it, our guide to hair loss after stopping finasteride covers what to expect for your hair.

Finasteride vs. dutasteride

In the Lee analysis, dutasteride 0.5 mg showed a smaller and statistically non-significant increase in sexual side effects (relative risk 1.37), but only 5 trials existed and the authors specifically warn that this does not mean dutasteride is safer. Our finasteride vs. dutasteride comparison goes through the efficacy side.

How to approach this decision

  1. See a doctor. Finasteride requires a prescription. A clinician can check that your hair loss is actually pattern hair loss and review your history, including any sexual or mood concerns you already have.
  2. Weigh the odds honestly. On the best available data, roughly 5 in 100 men on finasteride 1 mg reported a sexual side effect, against about 3 in 100 on placebo. For many men that trade is worth it, for some it is not.
  3. Decide in advance what would make you stop, and tell your doctor early if something changes. Do not tough it out silently.
  4. Do not combine the drug with online prescriptions or unregulated “finasteride alternatives” without medical advice.
  5. Track your hair with monthly photos, so you can judge benefit against any downside after 6 to 12 months.

If you prefer to avoid pills

Topical minoxidil is the over-the-counter option and works by a different mechanism. It does not lower DHT. It is not a one-to-one substitute, since finasteride tends to do better at stopping progression, but it has the strongest OTC evidence and no hormonal effects.

Our guide to using minoxidil and finasteride together explains how the two are commonly combined.

Summary

In placebo-controlled trials, finasteride 1 mg was associated with a modest increase in sexual side effects, about 5% versus 3% on placebo, with erectile dysfunction the clearest signal. The data have real limits: self-reported outcomes, uneven reporting, industry ties, and almost no information on long-term recovery. Most men tolerate it well, a minority do not, and the right decision is one you make with a doctor who knows your history.

This article is for informational purposes only and is not medical advice. Finasteride is a prescription medication. Talk to a healthcare provider before starting, changing, or stopping any treatment.